文献速递免疫规划慢病防控与筛查职业卫生

高血压与医护人员接种灭活SARS-CoV-2疫苗后的抗体应答及突破性感染相关

Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2.
PubMed 文献 · Vaccine · 2022-05-27

研究纳入101名接种两剂灭活疫苗(CoronaVac)的医护人员,于第二剂后1、3、5个月检测抗体,并另回顾性分析2714名接种者的突破性感染。结果发现抗体滴度在1个月时显著升高、3-5个月逐渐下降;年龄≥40岁与抗体水平显著相关,高血压及高血压病史与较低抗体滴度显著相关,回顾性研究亦显示高血压与突破性感染发生率显著相关。

要点

  • 接种两剂灭活疫苗后抗体滴度1个月显著升高,3-5个月逐渐下降。
  • 年龄≥40岁与抗体水平显著相关,性别和BMI对 antibody titres 无影响。
  • 高血压及高血压病史与较低抗体滴度显著相关,且与突破性感染发生率显著相关。

核心结论

  • 高血压与接种灭活SARS-CoV-2疫苗后较低抗体滴度和突破性感染相关。
  • 控制血压可能对提高灭活病毒疫苗效力重要。

研究设计与样本

  • 研究纳入101名接种两剂灭活病毒疫苗(CoronaVac)的医护人员,于第二剂后1、3、5个月分析血样。
  • 另项回顾性研究分析2714名接种两剂灭活病毒疫苗医护人员的突破性感染发生率,采用结构化自报问卷收集病史和人口学数据。

主要发现

  • 抗体滴度在接种后1个月显著升高,但在接种后3-5个月逐渐下降。
  • 年龄(≥40岁)与抗体水平显著相关,而性别和体重指数(BMI)对 antibody titres 无影响。
  • 分析临床变量中,高血压和高血压病史与较低抗体滴度显著相关。
  • 回顾性研究发现高血压与突破性感染发生率显著相关。

临床怎么用

  • 原文结论提示控制血压可能对提高灭活病毒疫苗效力重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Several types of vaccines have been developed to prevent the coronavirus disease 2019 (COVID-19). It is important to understand whether demographic and clinical variables affect the effectiveness of various types of vaccines. This study analysed the association between demographic/clinical factors, antibody response and vaccine effectiveness in healthcare workers vaccinated with inactivated virus. We enrolled 101 healthcare workers who received two doses of inactivated viral vaccine (CoronaVac). Blood samples were analysed at 1, 3, and 5 months after the second dose of vaccination. Data regarding demographic characteristics, medical histories, and clinical parameters were collected by interview and medical examination. In a separate retrospective study, we analysed the incidence of vaccine breakthrough infection on 2714 healthcare workers who received two doses of inactivated viral vaccine. Medical histories and demographic data were collected using a structured self-reported questionnaire. We found that antibody titres markedly increased at 1 month after vaccination but gradually decreased at 3-5 months post-vaccination. We observed a significant association between age (≥40 years) and antibody level, whereas sex and body mass index (BMI) exhibited no effect on antibody titres. Amongst clinical variables analysed, high blood pressure and history of hypertension were significantly correlated with lower antibody titres. Consistently, we found a significant association in the retrospective study between hypertension and the incidence of breakthrough infection. In conclusion, our results showed that hypertension is associated with lower antibody titres and breakthrough infection following COVID-19 vaccination. Thus, blood pressure control might be important to improve the efficacy of inactivated virus vaccine.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Soegiarto G, Wulandari L, Purnomosari D, et al. Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2. Vaccine. 2022. PMID: 35660034. doi:10.1016/j.vaccine.2022.05.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。